The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Amgen naming Billy Kelleher .

Filed returns
7
match these filters
Matching filed returns per period 0 1 2 3 5 Sep–Dec 2024: 3 filed returns Jan–Apr 2025: 1 filed returns May–Aug 2025: 1 filed returns Jan–Apr 2026: 1 filed returns May–Aug 2026: 1 filed returns 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Amgen EU Affairs Correspondence on the proposed EU Biotech Act, including Amgen's proposed amendments (Legislation) 3 On lobbying.ie
Jan–Apr 2026 Amgen Health Engagement with MEP Kelleher on EU legislations (Legislation) 1 On lobbying.ie
May–Aug 2025 Amgen Health Requested a meeting with MEP Kelleher to introduce Amgen and discuss EU General Pharma Legislation, Critical Medicines Act, and the upcoming Biotech Act (Legislation) 1 On lobbying.ie
Jan–Apr 2025 Amgen Health Email requesting a meeting with MEP Billy Kelleher to discuss EU legislation such as the Critical Medicines Act and upcoming Biotech Act (Legislation) 1 On lobbying.ie
Sep–Dec 2024 Amgen Health Requested meetings to discuss need to prioritize EU health policy and enhance EU competitiveness in biotech and life sciences in Ireland (Legislation) 5 On lobbying.ie
Sep–Dec 2024 Amgen Health Discussed EU competitiveness for biopharmaceutical industry investments at ALDE 2024 party conference roundtable; discussed Biotech Act, EU Pharma Legislation, and Draghi Report. (Legislation) 1 On lobbying.ie
Sep–Dec 2024 Amgen Health Highlight importance of EU Biotech Act and finalization/implementation of EU Pharma Legislation, European Health Data Space, In Vitro Diagnostic Regulation and Clinical Trials Act as part of EU competitiveness. (Legislation) 3 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 6 85.7%
EU Affairs 1 14.3%